Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Nanoviricides, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 32 | 36 | +4 |
| Shares | 1.34M | 1.46M | +117.3K (+8.7%) |
| Value | $2.01M | $2.09M | +$74.2K (+3.7%) |
New holders (7)
Institutions that held Nanoviricides, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 63,644 | $91.0K | 0.00% |
| Group One Trading, L.P. | 11,400 | $16.3K | 0.00% |
| BankPlus Trust Department | 7,000 | $10.0K | 0.00% |
| Bernard Wealth Management Corp. | 500 | $715 | 0.00% |
| FMR LLC | 86 | $123 | 0.00% |
| Ameriflex Group, Inc. | 100 | $120 | 0.00% |
| Wells Fargo & Company | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held Nanoviricides, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Dimensional Fund Advisors LP | 11,915 | $17.9K |
| Flaharty Asset Management, LLC | 400 | $600 |
| Parallel Advisors, LLC | 157 | $236 |